The current valuation score of Protagenic Therapeutics Inc is 6.29, ranking 309 out of 403 in the Biotechnology & Medical Research industry. Its current P/E ratio is 0.80, which is 12118.42% below the recent high of 97.85 and 2533.09% above the recent low of -19.48.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.